Products
Cardiosalin Protect 75 mg and 100 mg gastro-resistant tablets
| Generic name: | Acetylsalicylic acid |
| АТС code: | В01АС06 |
| Composition: | Each tablet contains 75 or 100 mg acetylsalicylic acid |
| Group: | Antithrombotic agents: platelet aggregation inhibitors excl. heparin |
OTC
Route (s) of administration: Oral use
Nature and contents of container:Cardiosalin Protect 75 mg - yellow, round, biconvex, gastro-resistant tablets.Cardiosalin Protect 100 mg - white, round, biconvex, gastro-resistant tablets
Contents of the package
Primary packaging
- Blister of PVC / PVdC / Al foil - ten (10) tablets in a blister
- HDPE jar with PP cap and dryer, one hundred (100) tablets per jar
Secondary packaging
- 3 or 4 blisters together with a patient leaflet in a cardboard box
- One jar together with a patient leaflet in a cardboard box
Description
Cardiosaline Protect (Acetylsalicylic acid) gastro-resistant tablets is a new drug for use in people over 18 years of age. It is used for secondary prevention of myocardial infarction and stroke, without a prescription.
Indications:
Cardiosalin Protect is indicated for:
- Secondary prevention of myocardial infarction;
- Prevention of cardiovascular disease in patients with stable angina pectoris;
- History of unstable angina pectoris, except during the acute phase;
- Prevention of graft occlusion after Coronary Artery Bypass Grafting (CABG);
- Coronary angioplasty, except during the acute phase;
- Secondary prevention of transient ischemic attacks (TIAs) and ischemic cerebrovascular accidents (CVAs), provided that intracerebral haemorrhages are ruled out.
Products manufactured under contract
| Generic name | Pharmaceutical form | АТС code |
|---|---|---|
| Acetylsalicylic acid | Tablets 500 mg | C01DA05 |
| Azithromycin | Hard capsules 250 mg | J01FA10 |
| Azithromycin | Powder for oral suspension 100 mg/5 ml, 20 ml | J01FA10 |
| Azithromycin | Powder for oral suspension 200 mg/5 ml, 20 ml | J01FA10 |
| Bifonazole | Cream 1%, 15 g | D01AC10 |
| Chloramphenicol | Hard capsules 250 mg | J01BA01 |
| Chloramphenicol | Ointment 2 %, 20 g | D06AX02 |
| Cinnarizine | Tablets 25 mg | N07CA02 |
| Clindamycin | Hard capsules 150 mg | J01FF01 |
| Clobetasol propionate | Cream 0,5 mg/g, 15 g | D07AD01 |
| Clobetasol propionate | Ointment 0,5 mg/g, 15 g | D07AD01 |
| Dequalinium chloride; Ascorbic acid | Compressed lozenges | C01DA05 |
| Dexamethasone, Tobramycin | Eye drops, suspension 3 mg/ml + 1 mg/ml, 5 ml | S01CA01 |
| Dimenhydrinate | Tablets 50 mg | R06AA00 |
| Doxycyclin | Hard capsules 100 mg | J01AA02 |
| Fluconazole | Hard capsules 50 mg | J02AC01 |
| Fluconazole | Hard capsules 100 mg | J02AC01 |
| Fluocinolone acetonide | Ointment 0,25 mg/g, 15 g | D07AC04 |
| Fluocinolone acetonide | Cream 0,25 mg/g, 15 g | D07AC04 |
| Fluocinolone acetonide, Neomycin | Cream 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
| Fluocinolone acetonide, Neomycin | Ointment 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
| Gentamicin | Cream 1 mg/g, 15 g | D06AX07 |
| Gentamicin | Ointment 1 mg/g, 15 g | D06AX07 |
| Gentamicin, Hydrocortisone | Cream 1 mg/g + 10 mg/g, 15 g | D07CA01 |
| Gentamicin, Hydrocortisone | Ointment 1 mg/g + 10 mg/g, 15 g | D07CA01 |
| Hydrochlorothiazide | Tablets 25 mg | C03AA03 |
| Hydrocortisone, Chloramphenicol | Eye drops, suspension 10 mg/ml + 2 mg/ml, 5 ml | S01CA03 |
| Hydrocortisone, Neomycin | Cream 10 mg/g + 3,5 mg/g, 15 g | D07CA01 |
| Hydrocortisone, Neomycin | Ointment 25 mg/g + 25 mg/g, 10 g | D07CA01 |
| Indapamide hemihydrate | Film-coated tablets 2,5 mg | C03BA11 |
| Isosorbide dinitrate | Tablets 10 mg | C01DA08 |
| Isosorbide dinitrate | Prolonged-realese tablets 20 mg | C01DA08 |
| Lincomycin | Hard capsules 500 mg | J01FF02 |
| Lovastatin | Tablets 20 mg | C10AA02 |
| Lovastatin | Tablets 40 mg | C10AA02 |
| Magnesium DL-aspartate tetrahydrate, Potassium DL-aspartate hemihydrate | Film-coated tablets 175 mg + 166 mg | A12BA30 |
| Metamizole sodium, Thiamine hydrochloride, Caffeine | Tablets 500 mg + 50 mg + 38,75 mg | N02BB52 |
| Nystatin | Cream 100 000 IU/g, 15 g | D01AA01 |
| Nystatin | Ointment 100 000 IU/g, 15 g | D01AA01 |
| Nystatin | Tablets 500 000 IU | A07AA02 |
| Oleandomycin, Dexamethasone, Indometacin | Oromucisal paste 50 mg/g + 10 mg/g + 50 mg/g, 5 ml | A01AD11 |
| Papaverine hydrochloride | Tablets 50 mg | A03AD01 |
| Pentaerithrityl tetranitrate | Tablets 10 mg | C01DA05 |
| Piracetam | Film-coated tablets 800 mg | N06BX03 |
| Piracetam | Hard Capsules 400 mg | N06BX03 |
| Propranolol hydrochloride | Tablets 20 mg | C07AA05 |
| Propranolol hydrochloride | Tablets 40 mg | C07AA05 |
| Rifampicin | Hard capsules 300 mg | J04AB02 |
| Tetracycline | Ointment 3 %, 20 g | D06AA04 |
| Tetracycline | Hard capsules 250 mg | J01AA07 |
| Tobramycin | Eye drops, solution 0,3 %, 5 ml | S01AA12 |
| Triamterene, Hydrochlorothiazide | Tablets 25 mg + 12,5 mg | C03EA01 |
| Troxerutin | Hard capsules 300 mg | C05CA04 |
New products
Aciclovir Vision 30 mg/g eye ointment
Subgroup: Antiinfectives, Antiviral products Medical product subject to medical prescription Route (s) of administration: Ocular use Nature and contents of container: The medicinal product is packe...
More
Prednisolon F 2 mg tablets
Subgroup: Glucocorticoids Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: 10 (ten) tablets are packed in a PVC / PVdC / AL fo...
More
Inosipranol 500 mg and 1000 mg powder for oral solution
Subgroup: Direct acting antivirals, Other antivirals Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: Inosipranol 500 m...
More
Clindavasin D 10 mg/ml cutaneous solution
Indications: Clindavasin D 10 mg/ml cutaneous solution is used to apply to the skin to treat acne vulgaris. Medical product subject to medical prescription Route (s) of administration: Clindavasin D...
More